An estimated one million people in Australia have sleep apnoea.
Globally the number is estimated to be about 100 million but only 10 per cent are treated. This number is expected to grow substantially with increased obesity and the ageing population. Four per cent of men and two per cent of women are affected by sleep apnoea. Most are undiagnosed. Up to 50 per cent of adults who suffer from sleep apnoea suffer from nasal obstruction.
Most oral devices used to treat sleep apnoea move the bottom jaw forward. This also pushes the tongue forward which opens the airway behind the tongue and stops it from falling backwards. The tongue is a common obstruction causing sleep apnoea.
The Oventus Clearway DeviceTM does this but has several additional unique features that make it a more comfortable device bypassing nasal, soft palate and tongue obstructions:
It has an airway about the size of a healthy nostril incorporated into it. This airway traverses between the teeth and the cheeks. The air enters the airway from outside the mouth and delivers it to the back of the throat behind where obstructions usually occur. About 60 per cent of people with sleep apnoea have nasal obstruction
- Small and streamlined
The Oventus Clearway DeviceTM is manufactured from medical grade titanium so the walls of the device are only 0.3mm thick. This allows us to build an airway into a more streamlined device that is less than 5mm thick as it passes between the teeth ? it?s about the size of a standard mouthguard. It?s also only one piece ? no moving parts.
The uniquely-designed mouthguard weighs only 10- 15 grams so is lightweight in your mouth.
The Oventus Clearway DeviceTM is lined with a soft medical grade dual laminated acrylic liner to maximise patient comfort. There is also no bulk on the tongue side of the device so it doesn?t reduce the space for your tongue. It actually increases the amount of room for your tongue.
Leave a Reply